Item 2.02. Results of Operations and Financial Condition
On October 22, 2009, Dynavax Technologies Corporation ("Dynavax"), issued a press release announcing its financial results for third quarter ended September 30, 2009. A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.
The information with respect to item 2.02 in this current report and its accompanying exhibit shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this current report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Dynavax, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Exhibit No. Description
99.1 Press Release, dated October 22, 2009 titled "Dynavax Announces Third Quarter 2009 Financial Results."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Dynavax Technologies Corporation
|
||||||||
|
Date: October 22, 2009
|
By:
|
/s/ Jennifer Lew
|
||||||
|
Jennifer Lew
|
||||||||
|
Vice President, Finance and Principal Accounting Officer
|
||||||||
EXHIBIT INDEX
|
Exhibit No.
|
Description
|
|
|
EX-99.1
|
Press Release, dated October 22, 2009 titled "Dynavax Announces Third Quarter 2009 Financial Results."
|